Company introduction

Lundbeck strives for global leadership in psychiatry and neurology by improving the lives of patients.

Main building of Lundbeck Headquarters

Lundbeck was founded by Hans Lundbeck as a trading company in 1915. In its early years, Lundbeck was solely a trading company, supplying Danish people with everything from synthetic sugar to silver paper. The recruitment of Eduard Goldschmidt in 1924 marked the beginning of Lundbeck’s ascent into the pharmaceutical industry, bringing several agencies for medicines into the company.

Read about Lundbeck’s history in more details.

Today, Lundbeck is a specialized pharmaceutical company focusing on psychiatry and neurology. For more than 70 years, we have been at the forefront of research within neuroscience. Our development and distribution of pioneering treatments continues to make a difference to people living with psychiatric and neurological disorders. Every day we strive for better treatments and improved quality of life for people living with psychiatric and neurological disorders.

Lundbeck is engaged in the entire value chain from research, development and production to marketing and sale of pharmaceuticals across the world. The company’s products are targeted at psychiatric and neurological disorders such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Lundbeck employs approximately 5,000 people worldwide.

Each year, Lundbeck ploughs around 20% of its revenue back into research and development of new pharmaceuticals to improve treatment options for people around the world suffering from psychiatric and neurological disorders, which makes it one of the world’s most research-intensive enterprises. Lundbeck employs approximately 1,000 highly-trained specialists in research and development activities located in Denmark and China.

Lundbeck’s production facilities are located in China, Denmark, France and Italy.

Lundbeck has affiliates in 55 countries, primarily focusing on sales, and our products are registered in more than 100 countries. In 2016, Lundbeck continued to make positive progress in International Markets and the US and we generated core revenue of DKK 15.6 billion.

If you are interested in more specific information about one of our affiliates, please visit their local websites


New corporate film

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders.

Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on